Alzheimer’s disease biomarkers measured from finger-prick dried blood samples closely match standard plasma tests and predict ...
News-Medical.Net on MSN
Finger-prick blood test shows promise for detecting Alzheimer’s disease biology
Finger-prick dried blood sampling can accurately measure key Alzheimer’s disease biomarkers, including p-tau217, GFAP, and ...
DUBLIN--(BUSINESS WIRE)--The "Capillary Blood Collection Devices Market - Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. Capillary Blood Collection Devices Market ...
BD MiniDraw™ Capillary Blood Collection System Enables Lab-Quality Blood Testing from Less Invasive Method than Venous Collection in More Convenient Locations FRANKLIN LAKES, N.J., Dec. 7, 2023 ...
The specimen of choice that enables the collection of small blood volumes from neonatal or critically ill patients is a capillary blood specimen. This specimen type has gained favour with many ...
DUBLIN--(BUSINESS WIRE)--The "Capillary Blood Collection Devices Market Analysis Report By Material (Plastic, Glass, Stainless Steel), By Product, By Application (Whole Blood, Plasma Tests), By End ...
Please provide your email address to receive an email when new articles are posted on . The BD MiniDraw device is part of a blood testing collection system that is designed to make routine blood tests ...
Background. Reliable reverse transcription polymerase chain reaction (RT-PCR)–based diagnosis of Ebola virus infection currently requires a blood sample obtained by intravenous puncture. During the ...
BD is expanding its long-running partnership with the blood collection company Babson Diagnostics, which aims to make taking a high-quality sample in pharmacies, grocery stores or at home as easy as ...
Modern blood testing is the foundation of clinical screening and decision-making. Timely disease diagnosis, prevention and chronic care management depend on accurate diagnostic testing. More than 7 ...
(RTTNews) - Medical technology company Becton, Dickinson and Co. or BD (BDX) announced Thursday it has received 510(k) clearances from the U.S. Federal Drug Administration (FDA) for a novel blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback